Commoney Wise
  • News
  • Politics
  • Business
  • Finance
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Futures
    • Forex
  • Crypto
  • Price Index
    • Stocks
    • Cryptocurrency
    • Commodities
    • Forex
  • Videos
  • Login
  • Register

  Breaking
Oil down 7% on week as dollar rockets on U.S. jobs report February 3, 2023
Japan stocks higher at close of trade; Nikkei 225 up 0.20% February 3, 2023
Loans to first-home buyers fall, while ASX defies inflation anxiety | Finance Report | ABC News February 3, 2023
Florida lawmakers to meet for special session next week to address Disney’s special governing powers February 3, 2023
Here’s a rapid-fire update on six Club stocks moving Friday on earnings February 3, 2023
Next
Prev

en English
en Englishes Españolde Deutschfr Françaisit Italianopt Portuguêsru Русскийzh-CN 简体中文hi हिन्दीja 日本語
Casino
  • News
  • Politics
  • Business
  • Finance
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Futures
    • Forex
  • Crypto
  • Price Index
    • Stocks
    • Cryptocurrency
    • Commodities
    • Forex
  • Videos
No Result
View All Result
Commoney Wise
Casino
  • News
  • Politics
  • Business
  • Economy
  • Finance
  • Investing
  • Markets
  • Crypto
  • Tech
  • Videos
Home Business

Amgen to buy Horizon Therapeutics for $26.4B

Staff by Staff
December 12, 2022
in Business
0 0
A A
0

Amgen announced on Monday that it will acquire Horizon Therapeutics in a $26 billion deal, extending the company’s 20-year commercial and medical legacy in inflammation and nephrology.

California-based Amgen will pay $116.50 in cash for each share of Horizon, which makes 12 marketed medicines and has a pipeline of more than 20 development programs.

The deal represented a premium of approximately 47.9% to the closing price of $78.76 per company share on Nov. 29, 2022, and a premium of roughly 19.7% to the closing price of $97.29 per share on Dec. 9, 2022.

“The acquisition is a compelling opportunity and is consistent with our strategy of delivering long-term growth by providing innovative medicines that address the needs of patients who suffer from serious diseases,” Amgen CEO Robert Bradway said in a statement.

CAN’T FIND CHILDREN’S TYLENOL? YOU MIGHT NOT NEED IT, DOCTORS SAY

“Additionally, the potential new medicines in Horizon’s pipeline strongly complement our own R&D portfolio.”

Ticker Security Last Change Change %
AMGN AMGEN INC. 278.65 -6.92 -2.42%
HPZN n.a. n.a. n.a. n.a.

Horizon CEO Tim Walbert said the company’s accomplishments were rooted in the employees’ deep commitment, dedication, and personal passion for those impacted by rare, autoimmune, and severe inflammatory diseases. 

“Amgen is aligned with that commitment and passion and will continue to maximize the value of the current portfolio and pipeline and accelerate the ability to reach more patients globally,” Walbert added. 

Horizon’s best-selling drug, Tepezza, is used to treat thyroid eye disease. Its revenue more than doubled last year to about $1.67 billion.

Read the full article here

ShareTweetSharePinShareSendShare
https://www.madmoneycasino.com/?faff=667&sub=DemCasino

Related Articles

Business

EY under fire over its two roles at battery start-up Britishvolt

February 3, 2023
Business

ETFs and your portfolio: Experts weigh in on what percentage to own

February 3, 2023
Business

Ukraine warns against complacency in face of Russian threat

February 3, 2023
Business

Bill Gates says Elon Musk not yet a ‘great philanthropist,’ calls going to Mars a waste of money

February 3, 2023
Business

Ford to return to Formula 1 with Red Bull deal after two-decade absence

February 3, 2023
Business

SEC considers easing climate-disclosure rules after investor pushback

February 3, 2023
Load More

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Commoney Wise

Commoney Wise is your one stop news website for the latest finance, business and crypto news, follow us to get the news that matters to your minute by minute.

Our Other Brands Kronosslott, Commoneywise, Demcasino.de, SportsExtremes.tv, Slotgamesusawwr, Coin Desk Times, Kingsofgolf.be

Topics

Business Commodities Crypto Economy Finance Forex Futures Investing Markets News Politics Stocks Tech Videos

Get Informed

The most important world news and events of the day

Be the first to know latest important news & events directly to your inbox.

By signing up, I agree to our TOS and Privacy Policy.

  • Privacy
  • Terms
  • Press
  • Advertise
  • Contact

© 2022 Commoney Wise. All Rights Reserved.

No Result
View All Result
  • News
  • Politics
  • Business
  • Finance
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Futures
    • Forex
  • Crypto
  • Price Index
    • Stocks
    • Cryptocurrency
    • Commodities
    • Forex
  • Videos

© 2022 Commoney Wise. All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.